FindTrial
Sign In

Comparison of fentanyl patch with oral diclofenac after third molar removal

Assessment of efficacy of fentanyl transdermal patch in pain control after third molar surgery in comparison to oral diclofenac administration A randomized case-control split mouth study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071808
Enrollment
40
Registered
2024-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K011- Impacted teeth

Interventions

Intervention1: Fentanyl Transdermal patch: transdermal fentanyl patch will be applied on chest after third molar removal and pain, swelling, trismus will be checked on immediate post op, day 3 and day

Sponsors

Minerva Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with bilaterally identical impacted third molars Patients with no systemic diseases i.e. ASA 1 Patients who give their informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients with systemic diseases i.e. ASA 2 or greater Patients with allergic to fentanyl or diclofenac Patients who do not give their informed consent to participate in the study

Design outcomes

Primary

MeasureTime frame
Fentanyl Transdermal patch is better in alleviating pain after third molar removal when compared to oral diclofenacTimepoint: Immediate post operative Post opeartive day 3 Post operative day 7—

Secondary

MeasureTime frame
Fentanyl Transdermal patch is better in alleviating swelling and trismus after third molar surgery when compared to oral diclofenacTimepoint: Immediate Post operative day and 3rd post operative day—

Countries

India

Contacts

Public ContactMinerva Singh

SGT University

ishasingla05@gmail.com8221855023

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026